Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
First to Fly Wins? Why the eVTOL Race Just Turned Contentious
FAA certification nears, but Archer’s patent fight with Vertical signals rising pressure in the electric air taxi sector.
How Iran Tensions Could Hit U.S. Gas Prices
Oil nears $79 as Iran tensions disrupt Hormuz and LNG halts. Timothy Cama, Politics & Influence Reporter at POLITICO’s E&E News, explains.
Go Fund Yourself: Rewriting the Ride & Rethinking the Exam Room
WAXii builds a driver-first rideshare for underserved markets starting in the Caribbean. Mylo redesigns medical tools for dignity, comfort & care efficiency.
Netflix Walks Away! Paramount in Lead to Scoop up Warner Bros. Discovery
Netflix Walks Away! Paramount in Lead to Scoop up Warner Bros. Discovery
Heart-Pounding Finish: Why This Beast Games Finale Changes Everything
Sean Klitzner, showrunner and co-creator of Beast Games, previews the Feb. 25 finale packed with bigger stunts, wild twists, and the highest stakes yet.
Inside the Explosive Case Accusing Social Media of Harming Kids
Maria Curi, tech policy reporter at Axios, breaks down Meta’s landmark trial as Zuckerberg testifies in a case that could reshape tech accountability.
